Axenya builds an integrated corporate-health orchestration platform anchored by two core products: LifeVault, an interoperable data lake that consolidates clinical, operational and administrative data; and Axenya IQ, a predictive AI/GenAI engine that anticipates risks, suggests interventions and optimizes care journeys. The company emphasizes end-to-end integration across employers, employees, insurers and providers rather than acting as a traditional broker. Reported client outcomes include medical inflation up to 50% below the market average, loss ratios 1,500 basis points lower than the national average, a 22% year‑over‑year reduction in total healthcare costs, a 40% drop in expenses for high‑risk patients and a 50% lower cost per procedure or consultation alongside a 13% increase in appointment volume. Founded in 2020 and based in São Paulo, Axenya plans to use new capital to accelerate commercial expansion and advance its technology roadmap, with particular focus on AI, data interoperability and connected biomarkers. The company has previously raised US$6.8 million in earlier rounds.

Total raised

$12M

Funding rounds

1

Latest round

Series A

Latest activity

Aug 2025